Ensign Group EBIT

The latest EBIT for ENSG is $500M as of June 2026. That compares with $420M in the prior-year period — up 19.9% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside Ensign Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENSG's EBIT moved from $420M to $500M — a 19.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ensign Group's operating scale or balance-sheet position.

Against Healthcare companies, ENSG currently prints $500M for EBIT, while the sector average sits near $130B. That is roughly 99.6% below the sector mean. Large gaps often invite a closer look at Ensign Group's growth, margins, and balance sheet.

A EBIT figure of $500M for ENSG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting ENSG's EBIT ($500M), review year-over-year change from $420M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.